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Background:  The efficacy of paclitaxel-coated balloon (PCB) has demonstrated for the treatment of drug-eluting stent (DES) restenosis 
lesions. However, there are currently not sufficient data that the pattern of restenosis had a significant impact on the outcomes after PCB 
angioplasty. We compared the angiographic outcomes by the pattern of restenosis.
methods:  Between September 2008 and September 2013, we treated 552 in-stent restenosis (ISR) lesions previously deployed DES 
using PCB (focal group: 198 lesions, diffuse group: 257 lesions, occlusion group: 32 lesions). Angiographic follow-up was routinely 
performed at 6-8 months after procedure. Follow up rate was 88.2%.
results:  Between the focal group, diffuse group and occlusion groups, reference diameter (2.92+/-0.42 mm vs. 2.87+/-0.44 mm vs. 
2.81+/-0.50 mm, p=0.3) was similar, lesion length (11.0+/-4.3 mm vs. 20.0+/-8.9 mm vs. 25.9+/-1.3 mm, p<0.0001) was longer in diffuse or 
occlusion group. Figure shows angiographic outcomes.
Conclusion:  The pattern of restenosis is a predictor of recurrent restenosis after PCB angioplasty for DES restenosis.
